Researchers

NISHIDA Naoshi

NISHIDA Naoshi: Specially Appointed Professor

Faculty	Department of Medicine / Graduate School of Medical Sciences
Researchmap	https://researchmap.jp/naoshinishida

Education and Career

Education

- 1985 , Osaka Medical College, Faculty of Medicine,
- 1993 , Kyoto University, Graduate School of Medicine,

Academic & Professional Experience

Apr. 2026 - Today , Kindai University Faculty of Medicine Department of Medicine Professor
Apr. 2021 - Mar. 2026 , Kindai University Faculty of Medicine Professor
Aug. 2011 - Mar. 2021 , Fuculty of Medicine Kindai University Department of Gastroenterology and Hepatology Associate Professor
Aug. 2006 - Jul. 2011 , Kyoto University Graduate School of Medicine Department of Gastroenterology and Hepatology Assistant Professor/Lecture
Feb. 2004 - Jul. 2006 , Baylor University Medical Center Division of Gastroenterology Reserach Associate
Apr. 1997 - Jan. 2004 , Kyoto University Graduate School of Medicine Department of Medicine and Clinical Science Assistant Professor
May. 1996 - Apr. 1997 , Research Institute for Production Development Researcher

Research Activities

Research Areas

Informatics, Biological, health, and medical informatics
Life sciences, Genomics
Life sciences, Gastroenterology

Research Interests

data base, artificial Intelligence, Molecular Biology, Hepatology, Gastroenterology, Epigenetics, chromosome, tumor suppressor gene, Hepatocellular carcinoma

Published Papers

Comparison of breast ultrasound image classification accuracy between convolutional neural networks and human experts using multicenter external validation cohort data.
Makoto Yamakawa; Tsuyoshi Shiina; Toshikazu Ito; Sadako-Tanaka Akashi; Kouzou Murakami; Takanori Watanabe; Hirotaka Morishima; Koichiro Tsugawa; Takayoshi Uematsu; Naoshi Nishida; Masatoshi Kudo
Journal of medical ultrasonics (2001) 26, Mar. 2026 , Refereed
Prospective Study of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma Based on Hepatobiliary Phase of Gd-EOB-DTPA-MRI.
Tomoko Aoki; Masatoshi Kudo; Kazuomi Ueshima; Masakatsu Tsurusaki; Keitaro Sofue; Yoshihiko Yano; Hidenori Toyoda; Atsushi Hiraoka; Takeshi Hatanaka; Atsushi Naganuma; Satoru Kakizaki; Norio Itokawa; Masanori Atsukawa; Kazuhito Kawata; Kazuto Tajiri; Joji Tani; Toru Ishikawa; Masahiro Morita; Hirokazu Chishina; Masahiro Takita; Satoru Hagiwara; Yasunori Minami; Takashi Kumada; Naoshi Nishida; Yuzo Kodama
Hepatology research : the official journal of the Japan Society of Hepatology 20, Mar. 2026 , Refereed
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study.
Mathew Vithayathil; Giulia Francesca Manfredi; Antonio D'Alessio; Claudia Angela Maria Fulgenzi; Ciro Celsa; Pasquale Lombardi; Aria Torkpour; Bernardo Stefanini; Peter R Galle; Naoshi Nishida; Bernhard Scheiner; Fionnuala Crowley; Linda Wu; Celina Ang; Thomas U Marron; Wei-Fan Hsu; Chun-Yen Lin; Ryan Po-Ting Lin; Susanna V Ulahannan; Haripriya Andanamala; Noha Soror; Ahmed Kaseb; Michael Lapelusa; Yehia I Mohamed; Martin Schönlein; Johann von Felden; Kornelius Schulze; Henning Wege; Brooke Wietharn; Caterina Vivaldi; Francesca Salani; Gianluca Masi; Tiziana Pressiani; Andrea Dalbeni; Leonardo Natola; Mariarosaria Marseglia; Fabio Piscaglia; Yi-Hsiang Huang; Pei-Chang Lee; Mario Pirisi; Alessandro Parisi; Natascha Rohlen; Robert Thimme; Marianna Silletta; Emanuela Di Giacomo; Bruno Vincenzi; Luca Galbato; Arndt Vogel; Giuseppe Cabibbo; Calogero Camma; Hong Jae Chon; Matthias Pinter; Alessio Cortellini; Masatoshi Kudo; Valentina Zanuso; Lorenza Rimassa; David J Pinato; Eric O Aboagye; Rohini Sharma
The Lancet. Digital health 8 (2) , 100952-100952, 12, Feb. 2026 , Refereed

Clinical Practice Guidelines for Hepatocellular Carcinoma , Naoshi Nishida , Tumor immune microenviroment of hepatocellular carcinoma and It's clinical implicaiton , Tumor immune microenviroment of hepatocellular carcinoma and It's clinical implicaiton , 医学書院 , Apr. 2025
Clinical Practice Guidelines for Hepatocellular Carcinoma , Naoshi Nishida , Clinical Significance of genomic and epigenetic alterations in hepatocellular carcinoma , Clinical Significance of genomic and epigenetic alterations in hepatocellular carcinoma , 医学書院 , Apr. 2025
Immunotherapy in Hepatocellular Carcinoma , Naoshi Nishida; Masatoshi Kudo , MDPI Books , Apr. 2023

Regression Model for Predicting the Glycolysis-Driven HCC Subclass , Tomoko Aoki; Naoshi Nishida; Masatoshi Kudo , JDDW2025、29th Annual Meeting of JSH, International Symposium 1 , 30, Oct. 2025
Immune Landscape of Intrahepatic cholangiocarcinoma and its Clinical Implication , Naoshi Nishida , APPLE 2025; The 15th Asia-Pacific Primary Liver Cancer Expert Meeting , 13, Jul. 2025
The Immune Microenvironment and Clinical Characteristics of Hepatocellular Carcinoma with Enhanced Glycolysis , Tomoko Aoki; Naoshi Nishida; Masahiro Morita; Hirokazu Chishina; Masahiro Takita; Satoshi Hagiwara; Yasunori Minami; Kazuomi Ueshima; Masatoshi Kudo , The 61st Annual Meeting of the Japan Liver Cancer Association , 10, Jul. 2025

【全領域をコンプリート! 超進化!AI時代の臨床検査】(3章)生理学的検査腹部超音波検査 , 西田直生志; 工藤正俊 , 検査と技術 , 53 , 8 , 896 , 902 , Aug. 2025
原発性肝がんのゲノム診断と臨床応用:新時代への挑戦 RNA発現量を用いたHCCのTIMEシグネチャ解析 , 青木智子; 西田直生志; 工藤正俊 , 肝臓 , 66 , Suppl.1 , A97 , A97 , Apr. 2025
肝疾患基礎研究from bench to bedside,未来の肝臓病学を考える(2) 肝細胞癌の代謝機能に基づいた新しい分子学的分類の提唱 , 青木智子; 西田直生志; 工藤正俊 , 肝臓 , 66 , Suppl.1 , A219 , A219 , Apr. 2025

Apr. 2026, The Japanese Society of Gastroenterology, Journal of Gastroenterology High Citation Award
Dec. 2025, Terumo Life Science Foundation, FY 2025 Medical Contribution Activity Subsidy
May. 2025, AME Publishing Company, Outstanding Authors

Terumo Life Science Foundation, FY 2025 Medical Contribution Activity Subsidy, Multimodal AI for Early Ultrasound Detection of Liver Cancer
日本学術振興会, 科学研究費助成事業, 胆道癌のドライバー変異に着目した腫瘍免疫微小環境の再構築と治療最適化 , 近畿大学
日本学術振興会, 科学研究費助成事業, 免疫チェックポイント阻害剤投与に伴う急速な腫瘍増大(HPD)の発症機序の解析 , 近畿大学